Inotiv Inc reports results for the quarter ended in September - Earnings Summary

Inotiv

11/12/2023 22:02

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss
of 38
cents​​ per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of -32
cents.  The mean expectation of four analysts for the quarter
was for a loss of 33 cents per share. Wall Street expected
results to range from -38 cents to -28 cents per share.
    * Revenue fell 6.5% to $140.74 million from a year ago;
analysts
expected $139.43 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of 38
cents​.
    * The company reported a quarterly loss of $9.66 million.
    * Inotiv Inc shares had risen by 9.7% this quarter and
lost 31.6%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is
$9.50 
This summary was machine generated from LSEG data December 11 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.33          -0.38          Missed
 Jun. 30 2023      -0.10          0.07           Beat
 Mar. 31 2023      -0.42          -0.39          Beat
 Dec. 31 2022      -1.30          -3.41          Missed